Literature DB >> 22532371

International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?

Friederike Erdmann1, Joannie Lortet-Tieulent, Joachim Schüz, Hajo Zeeb, Rüdiger Greinert, Eckhard W Breitbart, Freddie Bray.   

Abstract

The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair-skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied the global patterns and time trends in incidence of melanoma by country and sex, with a focus on and age- and cohort-specific variations. We analyzed the incidence data from 39 population-based cancer registries, examining all-ages and age-truncated standardized incidence rates of melanoma, estimating the annual percentage change and incidence rate ratios from age-period-cohort models. Incidence rates of melanoma continue to rise in most European countries (primarily Southern and Eastern Europe), whereas in Australia, New Zealand, the U.S., Canada, Israel and Norway, rates have become rather stable in recent years. Indications of a stabilization or decreasing trend were observed mainly in the youngest age group (25-44 years). Rates have been rising steadily in generations born up to the end of the 1940s, followed by a stabilization or decline in rates for more recently born cohorts in Australia, New Zealand, the U.S., Canada and Norway. In addition to the birth cohort effect, there was a suggestion of a period-related influence on melanoma trends in certain populations. Although our findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, they also indicate that those prevention measures require further endorsement in many countries.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22532371     DOI: 10.1002/ijc.27616

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  182 in total

1.  Quality, Readability, and Understandability of German Booklets Addressing Melanoma Patients.

Authors:  Julia Brütting; Lydia Reinhardt; Maike Bergmann; Dirk Schadendorf; Christiane Weber; Wolfgang Tilgen; Carola Berking; Friedegund Meier
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

Review 2.  Clinical applications of melanoma genetics.

Authors:  Michele Gabree; Devanshi Patel; Linda Rodgers
Journal:  Curr Treat Options Oncol       Date:  2014-06

3.  Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition.

Authors:  Saverio Caini; Giovanna Masala; Calogero Saieva; Marina Kvaskoff; Isabelle Savoye; Carlotta Sacerdote; Oskar Hemmingsson; Bodil Hammer Bech; Kim Overvad; Anne Tjønneland; Kristina E N Petersen; Francesca Romana Mancini; Marie-Christine Boutron-Ruault; Iris Cervenka; Rudolf Kaaks; Tilman Kühn; Heiner Boeing; Anna Floegel; Antonia Trichopoulou; Elisavet Valanou; Maria Kritikou; Giovanna Tagliabue; Salvatore Panico; Rosario Tumino; H B As Bueno-de-Mesquita; Petra H Peeters; Marit B Veierød; Reza Ghiasvand; Marko Lukic; José Ramón Quirós; Maria-Dolores Chirlaque; Eva Ardanaz; Elena Salamanca Fernández; Nerea Larrañaga; Raul Zamora-Ros; Lena Maria Nilsson; Ingrid Ljuslinder; Karin Jirström; Emily Sonestedt; Timothy J Key; Nick Wareham; Kay-Tee Khaw; Marc Gunter; Inge Huybrechts; Neil Murphy; Konstantinos K Tsilidis; Elisabete Weiderpass; Domenico Palli
Journal:  Int J Cancer       Date:  2017-03-09       Impact factor: 7.396

4.  Season of birth and other perinatal risk factors for melanoma.

Authors:  Casey Crump; Kristina Sundquist; Weiva Sieh; Marilyn A Winkleby; Jan Sundquist
Journal:  Int J Epidemiol       Date:  2014-01-22       Impact factor: 7.196

5.  The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.

Authors:  Céline Pinheiro; Vera Miranda-Gonçalves; Adhemar Longatto-Filho; Anna L S A Vicente; Gustavo N Berardinelli; Cristovam Scapulatempo-Neto; Ricardo F A Costa; Cristiano R Viana; Rui M Reis; Fátima Baltazar; Vinicius L Vazquez
Journal:  Cell Cycle       Date:  2016-04-22       Impact factor: 4.534

6.  Prevalence and predictors of recent skin examination in a population-based twin cohort.

Authors:  Kimberly A Miller; Bryan M Langholz; John Zadnick; Ann S Hamilton; Wendy Cozen; Thomas M Mack; Myles G Cockburn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-20       Impact factor: 4.254

7.  Prevention: lessons from a sunburnt country.

Authors:  Zoë Corbyn
Journal:  Nature       Date:  2014-11-20       Impact factor: 49.962

8.  Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines.

Authors:  K Vuong; B K Armstrong; M Drummond; J L Hopper; J H Barrett; J R Davies; D T Bishop; J Newton-Bishop; J F Aitken; G G Giles; H Schmid; M A Jenkins; G J Mann; K McGeechan; A E Cust
Journal:  Br J Dermatol       Date:  2019-09-22       Impact factor: 9.302

Review 9.  The discovery and development of binimetinib for the treatment of melanoma.

Authors:  Brian Tran; Mark S Cohen
Journal:  Expert Opin Drug Discov       Date:  2020-04-04       Impact factor: 6.098

Review 10.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.